Earnings History Data for Stoke Therapeutics, Inc. (STOK) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Stoke Therapeutics, Inc.
Stoke Therapeutics Inc. is a biopharmaceutical company. It develops antisense oligonucleotide medicines to treat genetic diseases. The company's product candidate consists of STK-001 which is to treat Dravet syndrome, a severe and progressive genetic epilepsy. Stoke Therapeutics Inc. is based in Bedford, Massachusetts.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-08-2024 | PM | STOK | Stoke Therapeutics | 708.00 | -0.46 | -0.57 | 0.00 | Stoke Therapeutics GAAP EPS of -$0.46, revenue of $4.83M [8/7/2024 9:25 AM] |
13.74 | -0.49 (-3.44%) |
0.0 | 0.0 (0.00%) |
3.35 - 17.58 | 461,081 | 450,000 | 0 | ||
| 06-05-2024 | PM | STOK | Stoke Therapeutics | 609.00 | -0.57 | -0.60 | 0.00 | Stoke Therapeutics GAAP EPS of -$0.57, revenue of $4.2M [5/6/2024 7:52 AM] |
11.83 | -0.19 (-1.58%) |
0.0 | 0.0 (0.00%) |
3.35 - 16.40 | 406,385 | 870,000 | 0 | ||
| 07-11-2023 | PM | STOK | Stoke Therapeutics | 189.00 | -0.55 | -0.65 | 0.00 | Stoke Therapeutics GAAP EPS of -$0.55 beats by $0.09, revenue of $3.31M beats by $0.24M [11/7/2023 8:25 AM] |
4.83 | 0.53 (12.18%) |
4.30 | -0.01 (-0.23%) |
3.35 - 14.00 | 190,598 | 140,000 | 196 | ||
| 07-08-2023 | PM | STOK | Stoke Therapeutics | 259.00 | -0.69 | -0.65 | 0.00 | Stoke Therapeutics GAAP EPS of -$0.69 misses by $0.06 [8/7/2023 7:20 AM] |
5.82 | -0.30 (-4.98%) |
5.70 | -0.42 (-6.86%) |
5.39 - 22.87 | 481,348 | 1,160,000 | 5,948 | ||
| 04-05-2023 | PM | STOK | Stoke Therapeutics | 435.00 | -0.53 | -0.70 | 0.00 | Stoke Therapeutics GAAP EPS of -$0.53 beats by $0.15, revenue of $5.15M beats by $1.65M [5/4/2023 12:25 PM] |
10.75 | 1.26 (13.28%) |
9.63 | 0.14 (1.48%) |
6.88 - 22.87 | 358,259 | 190,000 | 1,093 | ||
| 06-03-2023 | PM | STOK | Stoke Therapeutics | 341.00 | -0.65 | -0.72 | 0.00 | Stoke Therapeutics GAAP EPS of -$0.65 beats by $0.05, revenue of $3.27M beats by $0.41M [3/6/2023 7:24 AM] |
9.24 | 0.41 (4.64%) |
8.97 | 0.14 (1.59%) |
6.88 - 26.60 | 105,961 | 150,000 | 111 | ||
| 08-08-2022 | PM | STOK | Stoke Therapeutics | 640.00 | -0.63 | -0.70 | 0.00 | Stoke Therapeutics GAAP EPS of -$0.63 beats by $0.05, revenue of $3.2M beats by $0.18M [8/8/2022 8:40 AM] |
21.37 | 4.58 (27.28%) |
17.40 | 0.61 (3.63%) |
9.54 - 33.06 | 359,689 | 170,000 | 406 | ||
| 10-05-2022 | PM | STOK | Stoke Therapeutics, Inc. | 550.36 | -0.66 | 0.61 | -0.46 | Stoke Therapeutics GAAP EPS of -$0.66 misses by $0.98, revenue of $3M misses by $34.5M [5/10/2022 7:43 AM] |
13.69 | 1.00 (7.84%) |
12.69 | 0.0 (0.00%) |
12.59 - 41.60 | 360,461 | 326,061 | 222,261 | ||
| 10-03-2022 | PM | STOK | Stoke Therapeutics | 723.00 | -0.66 | -0.62 | 0.00 | Stoke Therapeutics GAAP EPS of -$0.66 misses by $0.04 [3/10/2022 7:48 AM] |
20.63 | -0.15 (-0.72%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 31,314 | 0 | 0 | ||
| 08-11-2021 | PM | 7:00 AM ET (Nov 8) |
STOK | Stoke Therapeutics | 956.00 | -0.61 | -0.58 | 0.00 | Stoke Therapeutics EPS misses by $0.02 [11/8/2021 7:22 AM] |
26.64 | 0.67 (2.58%) |
25.97 | 0.0 (0.00%) |
21.42 - 71.58 | 129,378 | 110,000 | 1,370 | |
| 10-08-2021 | PM | STOK | Stoke Therapeutics, Inc. | 984.50 | -0.60 | -0.49 | -0.39 | Stoke Therapeutics EPS misses by $0.12 [8/10/2021 8:28 AM] |
25.94 | -0.41 (-1.56%) |
25.94 | 0.0 (0.00%) |
24.62 - 71.58 | 75,723 | 140,000 | 572 | ||
| 10-05-2021 | PM | STOK | Stoke Therapeutics, Inc. | 1,152 | -0.46 | -0.44 | 0.00 | Stoke Therapeutics EPS misses by $0.02 [5/10/2021 7:57 AM] |
33.03 | 0.57 (1.76%) |
32.46 | 0.0 (0.00%) |
22.00 - 71.58 | 148,020 | 210,000 | 1,384 | ||
| 09-03-2021 | PM | STOK | Stoke Therapeutics, Inc. | 1,808 | -0.42 | -0.43 | 0.00 | Stoke Therapeutics EPS in-line [3/9/2021 8:02 AM] |
51.85 | 1.37 (2.71%) |
50.48 | 0.0 (0.00%) |
15.82 - 71.58 | 277,050 | 166,956 | 105 | ||